Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RNDr. Ronald Nahass

    Dr. Ronald Nahass

    Infectious Disease · General Infectious Disease
    IDSA
    ronald

    Research

    GS143, an Inhibitor of E3 Ligase β-TrCP, Reverses HIV-1 Latency Without Activating T Cells via Unconventional Activation of NFκB

    2025

    Via PLoS Pathogens

    Research

    Genetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS-CoV-2 Infection With and Without Diabetes

    2025

    Via Journal of Medical Virology

    Research

    Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1: A Phase 2 Randomized Study

    2025

    Via Annals of Internal Medicine

    Research

    Long-Term Open-Label Vebicorvir for Chronic HBV Infection: Safety and Off-Treatment Responses

    2024

    Via JHEP Reports: Innovation in Hepatology

    Research

    Development of a Dual Channel Detection System for Pan-Genotypic Simultaneous Quantification of Hepatitis B and Delta Viruses

    2024

    Via Emerging Microbes & Infections

    Research

    Relationship Between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin—Preclinical and Clinical Evidence

    2023

    Via Pharmaceutics

    Research

    Randomised Phase 2 Study (JADE) of the HBV Capsid Assembly Modulator JNJ-56136379 With or Without a Nucleos(t)ide Analogue in Patients With Chronic Hepatitis B Infection

    2023

    Via Gut

    Research

    Successful Treatment of Prosthetic Joint Infection With Single-Stage Exchange and Oral Antibiotics

    2023

    Via Open Forum Infectious Diseases

    Research

    The Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis

    2023

    Via Pharmacy (Basel)

    Research

    Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis

    2022

    Via Open Forum Infectious Diseases

    Research

    Safety and Efficacy of Vebicorvir in Virologically Suppressed Patients With Chronic Hepatitis B Virus Infection

    2022

    Via Journal of Hepatology

    Research

    Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Cohort Study

    2022

    Via Annals of Internal Medicine

    Research

    Safety and Efficacy of Vebicorvir Administered With Entecavir in Treatment-Naïve Patients With Chronic Hepatitis B Virus Infection

    2022

    Via Journal of Hepatology

    Research

    Health-Related Quality of Life in People Receiving Opioid Agonist Treatment and Treatment for Hepatitis C Virus Infection

    2022

    Via Journal of Addictive Diseases

    Research

    Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study

    2021

    Via Clinical Infectious Diseases